The benefits of nutrigenomics tools to illuminate the effect of certain nutrients on genes are occurring right now, but talk of personalized nutrition should be left for the future, says a DSM corporate scientist.
In the fourth part of our nutrigenomics special edition NutraIngredients takes a look at how the field could help to deliver a more personal approach to nutrition in the future.
Understanding the fine details of physiology, rather than looking at surrogate biomarkers of health and disease, can open up new doorways and a ‘goldmine’ of information on how the diet affects our health, according to a leading nutrigenomics expert.
At the recent IFT Annual Meeting and Expo, Stephen Daniells talked to Dr Jim Kaput, director of FDA’s Division of Personalized Nutrition and Medicine about the paradigm shift needed to move personalized nutrition forward.
The large majority of American consumers are ready to embrace nutrigenomics, according to a recent survey that gauged views on the concept of personalized nutrition.
Omega-3-rich fish oil beneficially affects gene expression, says a new nutrigenomic study that enhances our understanding of the health benefits of omega-3.
Ready-to-buy human genomes will facilitate the development of
dietary supplements tailored to patching genetic flaws, according
to University of California (UC) researchers.
Nutrigenetically tailored diets can result in better compliance
with weight management goals, as well as longer-term BMI
reduction and improvements in blood glucose levels, says new
research.
Chr Hansen regards nutrigenomics as technology to underlie the food
industry's future away from one-size-fits-all nutrition, and has
placed exploration of this area high-up on its R&D agenda.
Companies offering personalised nutrition testing are jumping the
gun because the science behind nutrigenomics is not enough to
support the claims, says an article in New Scientist.
Science fiction or science fact? Could we soon be stopping off for
a quick genetic test to let us know which foods and supplements to
take to reduce our risks of certain diseases?
WellGen has secured $3 million in series B financing, which it will
use to fund human clinical trials of its ingredients developed
through nutrigenomics to target obesity and inflammation.
